Insiders AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:23 23/06/2025 BST			5-day change	1st Jan Change
10,420.00 ^GBX	+0.27%		-3.68%	-0.46%

06-02	ASTRAZENECA : Buy rating from JP Morgan	ZD
06-02	UK's FTSE 100 closes around flat as staples, healthcare losses eclipse energy gains	RE

Insiders

Perrigo Company plc Announces Executive Changes	06-04	CI
Bodycote revenue falls; Inspired mulls possible offer	05-27	AN
AstraZeneca chief executive joins Agilent Technologies board	05-21	AN
Agilent Technologies Inc. Announces Board Changes, Effective May 21, 2025	05-21	CI
Compugen Ltd. Announces Management Changes	05-13	CI
Compugen Ltd. Announces Chief Executive Officer Changes	05-13	CI
Syndax Pharmaceuticals Appoints Nicholas Botwood as Head of Research and Development and Chief Medical Officer	05-12	CI
PRESS DIGEST-British Business - April 30	04-30	RE
AstraZeneca Gets Profit Boost From Diabetes, Cancer Drugs	04-29	MT
Protara Therapeutics, Inc. Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer	04-15	CI
AstraZeneca PLC Appoints Karen Knudsen as Director	04-11	CI
Rocket Pharmaceuticals, Inc Appoints Sarbani Chaudhuri as Chief Commercial & Medical Affairs Officer, Effective from April 7, 2025	04-07	CI
BP Chair to step down; AstraZeneca touts EU approval	04-04	AN
AB Foods says Primark CEO leaves after investigation	03-31	AN
Xeris Biopharma Holdings, Inc. Announces Changes to Its Board of Directors	03-28	CI
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals	03-21	RE
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals	03-21	RE
Adherium Limited Plans for Board Changes	03-21	CI
AstraZeneca PLC Announces Board and Committee Changes	02-18	CI
AstraZeneca: announces two appointments in France	02-10	CF
AstraZeneca CEO says company has no access to executive Wang, in detention in China	02-06	RE
AstraZeneca CEO says company has no access to executive Wang, in detention in China	02-06	RE
Drugmaker AstraZeneca flags possible $4.5 million Chinese tax fine	02-06	RE
Indivior completes USD100 million share buyback	02-04	AN
EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO	01-28	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Sustained operational strength leads to an upgrade

May 20, 2025 at 03:42 pm

AstraZeneca Gets Profit Boost From Diabetes, Cancer Drugs

April 29, 2025 at 10:46 am